ロード中...
Practical Management of Bevacizumab-Related Toxicities in Glioblastoma
Bevacizumab, currently an option for treatment of different types of tumors including glioblastoma, has a peculiar toxicity profile related to its antiangiogenic effect. Because some bevacizumab-related adverse events can be life threatening, it is important to identify risk factors and to establish...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AlphaMed Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319633/ https://ncbi.nlm.nih.gov/pubmed/25568148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0330 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|